| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d5bb9b9a6d998b72b154ceb1895a3f5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-02 |
| filingDate |
2004-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aea6ea92570ac42b5130f13af4f4d46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3847614aa2f5041b78c83bd9d5224c3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83695bce277974e6f925f8bdf59f0aa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fec50bc49885c51e1266c271f3db7500
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47d3aad6bf7e97f6ba78775402e2a369
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15400574ddbae6769aaf78a61cf8f138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaef8d56fa048152db6063a50eadb04b |
| publicationDate |
2010-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7648998-B2 |
| titleOfInvention |
Imidazo 4,5-c pyridine compounds and methods of antiviral treatment |
| abstract |
The present invention relates to a pharmaceutical composition for the treatment or prevention of viral infections comprising as an active principle at least one imidazo[4,5-c]pyridine prodrug having the general Formula (A) wherein the substituents are described in the specification. The invention also relates to processes for the preparation and screening ofcompounds according to the invention having above mentioned general Formula and their use in the treatment or prophylaxis of viral infections. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8492386-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815858-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8680106-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8809265-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8993578-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9944880-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8466159-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8685984-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8853176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969357-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010004281-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010028301-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8779141-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9452194-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011146817-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11192914-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8329727-B2 |
| priorityDate |
2003-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |